» Articles » PMID: 36652443

Ebola Virus Disrupts the Inner Blood-retinal Barrier by Induction of Vascular Endothelial Growth Factor in Pericytes

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2023 Jan 18
PMID 36652443
Authors
Affiliations
Soon will be listed here.
Abstract

Ebola virus (EBOV) causes severe hemorrhagic fever in humans with high mortality. In Ebola virus disease (EVD) survivors, EBOV persistence in the eyes may break through the inner blood-retinal barrier (iBRB), leading to ocular complications and EVD recurrence. However, the mechanism by which EBOV affects the iBRB remains unclear. Here, we used the in vitro iBRB model to simulate EBOV in retinal tissue and found that Ebola virus-like particles (EBO-VLPs) could disrupt the iBRB. Cytokine screening revealed that EBO-VLPs stimulate pericytes to secrete vascular endothelial growth factor (VEGF) to cause iBRB breakdown. VEGF downregulates claudin-1 to disrupt the iBRB. Ebola glycoprotein is crucial for VEGF stimulation and iBRB breakdown. Furthermore, EBO-VLPs caused iBRB breakdown by stimulating VEGF in rats. This study provides a mechanistic insight into that EBOV disrupts the iBRB, which will assist in developing new strategies to treat EBOV persistence in EVD survivors.

Citing Articles

Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review.

Zhao Y, Tang Y, Wang Q, Li J Front Immunol. 2025; 16:1515768.

PMID: 39967658 PMC: 11832381. DOI: 10.3389/fimmu.2025.1515768.


Hippo signaling pathway regulates Ebola virus transcription and egress.

Liang J, Djurkovic M, Leavitt C, Shtanko O, Harty R Nat Commun. 2024; 15(1):6953.

PMID: 39138205 PMC: 11322314. DOI: 10.1038/s41467-024-51356-z.


SARS-CoV-2 infects cells lining the blood-retinal barrier and induces a hyperinflammatory immune response in the retina via systemic exposure.

Monu M, Ahmad F, Olson R, Balendiran V, Singh P PLoS Pathog. 2024; 20(4):e1012156.

PMID: 38598560 PMC: 11034659. DOI: 10.1371/journal.ppat.1012156.


Contrasting effects of filamin A and B proteins in modulating filovirus entry.

Shepley-McTaggart A, Liang J, Ding Y, Djurkovic M, Kriachun V, Shtanko O PLoS Pathog. 2023; 19(8):e1011595.

PMID: 37585478 PMC: 10461817. DOI: 10.1371/journal.ppat.1011595.

References
1.
Wahl-Jensen V, Afanasieva T, Seebach J, Stroher U, Feldmann H, Schnittler H . Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol. 2005; 79(16):10442-50. PMC: 1182673. DOI: 10.1128/JVI.79.16.10442-10450.2005. View

2.
Diallo B, Sissoko D, Loman N, Bah H, Bah H, Worrell M . Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clin Infect Dis. 2016; 63(10):1353-1356. PMC: 5091350. DOI: 10.1093/cid/ciw601. View

3.
Liu H, Qiu K, He Q, Lei Q, Lu W . Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis. J Neuroimmune Pharmacol. 2018; 14(2):157-172. DOI: 10.1007/s11481-018-9821-6. View

4.
Diaz-Coranguez M, Lin C, Liebner S, Antonetti D . Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability. J Biol Chem. 2020; 295(14):4647-4660. PMC: 7135996. DOI: 10.1074/jbc.RA119.011273. View

5.
Deissler H, Deissler H, Lang G . Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells. Br J Ophthalmol. 2011; 95(8):1151-6. DOI: 10.1136/bjo.2010.192229. View